IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $83,000 | -63.3% | 8,616 | +77.0% | 0.01% | 0.0% |
Q4 2020 | $226,000 | +41.2% | 4,869 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $160,000 | -70.3% | 4,869 | -75.2% | 0.00% | -66.7% |
Q2 2020 | $539,000 | -10.5% | 19,627 | -2.5% | 0.01% | -14.3% |
Q1 2020 | $602,000 | -14.6% | 20,121 | -21.0% | 0.01% | -12.5% |
Q4 2019 | $705,000 | +95.8% | 25,473 | -32.7% | 0.02% | +100.0% |
Q1 2019 | $360,000 | +7.5% | 37,870 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $335,000 | +6.7% | 37,870 | +35.6% | 0.01% | +14.3% |
Q3 2018 | $314,000 | – | 27,937 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,674,299 | $65,948,000 | 5.28% |
Ghost Tree Capital, LLC | 700,000 | $17,262,000 | 5.05% |
Perceptive Advisors | 11,489,772 | $283,337,000 | 4.12% |
Prosight Management, LP | 274,761 | $6,776,000 | 3.73% |
Fairmount Funds Management LLC | 389,588 | $9,607,000 | 3.49% |
Avoro Capital Advisors LLC | 8,500,000 | $209,610,000 | 3.29% |
ACUTA CAPITAL PARTNERS, LLC | 374,495 | $9,235,000 | 3.26% |
Ally Bridge Group (NY) LLC | 406,986 | $10,036,000 | 2.95% |
Parametrica Management Ltd | 146,362 | $3,609,000 | 2.70% |
COMMODORE CAPITAL LP | 362,869 | $8,948,000 | 2.36% |